Organic Sales Growth: 7% increase. Segment Margins: Expanded 180 basis points to 16.7%. Adjusted EPS: Increased 19% to $0.82. Orders Growth: Up 5%. Backlog: Grew 12% to $14 billion. Available Cash: Approximately $800 million. Net Debt: Decreased to 2.4 times. Adjusted Free Cash Flow: …
Net Income: $300,000 or $0.01 per diluted share; adjusted net income of $4 million or $0.12 per diluted share. Revenue: Declined slightly due to lower commodity prices. Gross Profit: Improved despite increased expenses. Adjusted Pre-Tax Earnings: $3 million, down from $7 million in 2024. …
Organic Revenue Growth: 6% year-over-year increase. Adjusted EBITDA Margin: Expanded by 400 basis points year-over-year. Sample Management Solutions Revenue: Grew 8% on an organic basis. Multiomics Revenue: Grew 3% on an organic basis. Non-GAAP EPS: $0.05 per share. Free Cash Flow: $7 million for …
Q4 Revenue: $6.4 billion, up nearly 4% year-over-year. Q4 Adjusted Operating Margin: 6.2%, a quarterly record. Q4 Adjusted EPS: $0.73, up 28% year-over-year. Full Year Revenue FY25: $25.8 billion, down 2% year-over-year. Full Year Adjusted Operating Margin FY25: 5.7%, a record level. Full Year …
Revenue: Increased 11% year-over-year to $72 million. Non-GAAP Earnings Per Share (EPS): Rose 69% to $0.27. Cash Flow from Operations: $22.4 million. Cloud Security ARR: Increased 19% year-over-year to $80 million. Total ARR: Grew 9% year-over-year to $230 million. Recurring Revenues: 82% of total …
Reported Sales: Down 6% year-over-year. Organic Sales: Declined 4% year-over-year. Segment Operating Margin: 20.4%, up from 19% a year ago. Adjusted EPS: $2.45, above expectations. Free Cash Flow: $171 million, $102 million higher than the prior year. Free Cash Flow Conversion: 61% in the …
Reported EPS: $1.48 compared to $1.68 in Q1 2024. Adjusted EPS: $1.81 versus $3.04 in the prior year. Adjusted EBIT: $406 million compared to $719 million last year. Adjusted Funds from Operations: $392 million. Discretionary Cash Flow Available: $338 million after sustaining CapEx. Dividends …
Release Date: May 07, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points LivaNova PLC (NASDAQ:LIVN) achieved 10% organic revenue growth in Q1 2025, marking the 8th time in the past 9 quarters with …
Earnings Per Share (EPS): $1, a $0.07 increase over the same quarter last year. Net Earnings: $499 million for the quarter. Capital Investment: $1.4 billion invested in utility systems during the quarter. Rate Base Growth: Expected to increase by approximately $14 billion to $53 …
Revenue: $841 million, up 3% organically and 10% after adjustments. ARR (Annual Recurring Revenue): $2.11 billion, up 17% organically. EPS (Earnings Per Share): $0.61, ahead of expectations. Gross Margin: Expanded 180 basis points to 69.9%. EBITDA Margin: 25.9%, a 100 basis points expansion year …